Wat zijn de openingstijden?

Maandag 09:00 - 17:00 Dinsdag 09:00 - 17:00 Woensdag 09:00 - 17:00 Donderdag 09:00 - 17:00 Vrijdag 09:00 - 17:00

HemoClear

Red Blood Cell Filter enabling autologous blood transfusion

24/07/2025

Cell Salvage process optimization drives quality

An analysis of 238 centrifugal cell salvage procedures (154 men, 84 women) demonstrated that quality control benchmarks were consistently achieved, reinforcing the reliability of autologous transfusion in surgical care.

Nevertheless, some variability was observed:
🔴Hematocrit targets were not met in 22% of cases
🔴Total protein elimination was insufficient in 8%

Patient-specific factors, such as age, gender, and surgical indication, had minimal impact on these outcomes.

Instead, variability was driven in nonemergency cases, by technical and procedural conditions, such as:
🔵 Low collection volumes
🔵 Excessive dilution with irrigation fluids

Anesthesiologists play a pivotal role in ensuring the quality of autologous transfusion. With real-time awareness, they adapt collection and wash parameters, even in complex or suboptimal surgical conditions, to uphold transfusion standards and protect patient outcomes.

Curious to test microfiltration technology under similar conditions, independent of centrifugal systems?

✉️ Contact us at info@https://bit.ly/419jNT1
🌐 Visit https://bit.ly/419jNT1
📑 Reference: https://bit.ly/4lPn56q

22/07/2025

Advancing Intraoperative Blood Management in Spine Surgery

In Adult Spine Deformity (ASD) surgery, where intraoperative blood loss is often significant, cell salvage plays a critical role in reducing reliance on allogenic transfusions and improving perioperative outcomes.

Key clinical and economic advantages include:
✅ Reduction in allogenic transfusion rates by 18–33%
✅ Preservation of 0.3–1 unit of donor blood per patient, when transfusion is still required
✅ Greatest efficacy observed in procedures with blood loss ≥15 mL/kg
✅ Potential cost savings up to $422 per case

Hemoclear introduces a novel solution, a straightforward, single-use microfiltration system that enables broader access to platelet-rich autologous blood reinfusion. By eliminating the complexity of conventional systems, Hemoclear offers an adaptable and cost-effective approach to intraoperative blood recovery.

Learn more: info@hemoclear.com | 🌐 https://bit.ly/3Ck6OB9

17/07/2025

Can safe and efficient blood recovery be achieved during C-sections in low-resource settings?
A newly published study in the International Journal of Gynecology & Obstetrics offers a resounding yes.

Researchers evaluated the HemoClear microfiltration system in cesarean sections at a South African tertiary hospital, and the results are compelling.

Key findings and clinical highlights
🩸75.5% erythrocyte recovery, with strong platelet retention
🩸Safe bacterial profile and >75% removal of α-fetoprotein, supporting reinfusion safety
🩸No electricity, centrifuge, or costly equipment needed
🩸Filtration completed in ~15 minutes, making it workflow-compatible

The authors conclude that HemoClear could significantly enhance obstetric care in LMICs, where blood shortages and transfusion risks are prevalent. This gravity-driven solution offers affordable, portable, and practical cell salvage, exactly where it's needed most.

📄 Full article: https://bit.ly/4eUteeD

15/07/2025

HemoClear aligns with all five strategic goals of the EU’s Stockpiling and Medical Countermeasures Strategies, directly supporting Europe's crisis readiness and health security.

1️⃣ Threat Intelligence & Early Response
Our equipment and electricity free autologous blood transfusion solution enhances clinical resilience in disaster zones and outbreak scenarios.

2️⃣ Accelerating Medical Countermeasures (MCM)
By enabling donation-independent blood transfusion and positioning convalescent plasma as a frontline treatment in future pandemics, HemoClear provides a scalable and innovative approach to lifesaving interventions.

3️⃣Agile Manufacturing
HemoClear is manufacturing-ready for rapid scale-up and partnerships.

4️⃣Stockpiling & Procurement
As a non-perishable, storable device, it fits perfectly into joint procurement strategies for future readiness.

5️⃣Civilian-Military Coordination & Training
Versatile across sectors, HemoClear builds capacity and empowers decentralised preparedness through a straightforward blood processing procedure.

One innovation, five strategic impacts.

19/06/2025

Join us at the Combat Medical Care Conference 2025 in Ulm, Germany.

HemoClear is proud to participate in the SOF Workshop on July 1st, held on the occasion of the 2025 Combat Medical Care Conference, the international symposium on Tactical Combat Casualty Care for medics, EMTs, paramedics, nurses, and physicians operating in military and law enforcement missions.

We look forward to connecting with frontline professionals to explore the role of autologous blood transfusion even in Role I settings, where conventional cell savers and electricity are unavailable.

HemoClear’s gravity-driven blood filtration system offers a unique solution to treat severe bleeding in austere environments.

17/06/2025

New Publication Alert

In a recently published case report, we explore the successful treatment of myasthenia gravis (MG) following long COVID in a 71-year-old patient, using HemoClear gravity-driven plasma exchange.

Despite initial deterioration and resistance to standard therapy, the patient showed marked clinical improvement following low-volume plasmapheresis using HemoClear’s straightforward and cost-effective gravity-driven microfiltration technology.

This case highlights the value of accessible innovations like HemoClear in managing complex post-COVID autoimmune conditions, where conventional treatments may be unavailable.

Read the full case: https://bit.ly/3Hxwr7m
Efficacy of Plasma Exchange in Myasthenia Gravis Following Long COVID in a Resource-Limited Context

12/06/2025

What if patients didn’t have to rely on others for life-saving blood?

With breakthrough cell salvage technology like HemoClear, patients can receive their own freshly micro-filtered blood, right in the OR or recovery room. No machines, no electricity, no donor blood needed.

HemoClear empowers clinicians to deliver:
🔹Platelet-rich transfusion blood.
🔹100% biologically compatible transfusions
🔹 Ultra-low risk of transfusion-related infections or immune reactions
🔹 Simpler workflows, no crossmatch or complex logistics
🔹 Patient's independence from donor systems

This next-generation patient blood management makes blood transfusion safer, smarter, and sustainable.

Check out how: https://www.hemoclear.com/

10/06/2025

Cell salvage reduces transfusions in complex scoliosis surgeries. What if you had access to that capability with greater flexibility and ease?

HemoClear is a breakthrough micro-filtration system that enables high-quality, gravity-driven cell salvage, without the need for machines or electricity. Designed for simplicity, mobility, and performance in the OR.

HemoClear recovers high volumes of red cell and platelets!

Ideal for both pediatric and adult spine surgeries, HemoClear supports reduced transfusion rates, lower surgical costs, and fewer complications, empowering safer, more efficient care.

Learn more https://www.hemoclear.com/

05/06/2025

In times of crisis, blood donation services are often the first to collapse, whether due to pandemics like COVID-19 or the devastating impact of war. Yet, the need for safe blood transfusions doesn’t disappear.

HemoClear enables doctors and nurses collecting a patient’s own blood during surgery or trauma, filtering it bedside, and re-infusing high-quality blood within 25 minutes, without relying on donor blood or electricity.

Thanks to the efforts of Operation Aid, HemoClear is now helping healthcare workers in Ukraine deliver high-quality transfusions under extreme conditions.

👉 Want to support OperationAid? Visit their website https://bit.ly/4kONvnO
👉 Want to donate HemoClear to a region with a disrupted healthcare system? Contact us at info@hemoclear.com.

03/06/2025

Transforming maternal care with new technology.

New evidence shows that cell salvage during caesarean birth helps reduce the need for donor blood, minimize blood loss, and increase postpartum haemoglobin, a meaningful advancement in improving outcomes for mothers.

Six clinical trials involving 3,476 women in high- and upper-middle-income countries reported no cases of amniotic fluid embolism.

HemoClear’s gravity-driven, equipment-free blood micro-filtration technology enables safe, bedside cell salvage, offering a practical alternative to traditional transfusion systems and modernizing maternal care delivery.

🔗 Learn more: https://www.hemoclear.com/

29/05/2025

1 in 7 hospital patients needs a blood transfusion , but global blood supply chains are fragile and easily disrupted.

From pandemics to conflict zones, every crisis exposes the weaknesses in traditional transfusion systems.

HemoClear delivers a breakthrough: a donor-free, autologous transfusion technology that works without electricity or complex logistics, providing safe, high-quality platelet-rich blood where it's needed most.

Check out how https://www.hemoclear.com/

Built for resilience. Designed for impact.

https://www.hemoclear.com/cell-salvage-filter-procedure-that-includes-blood-washing-blood-cell-saver-or-cell-salvage/

Adres

Dokter Stolteweg 70A
Zwolle
8025AZ

Openingstijden

Maandag	09:00 - 17:00
Dinsdag	09:00 - 17:00
Woensdag	09:00 - 17:00
Donderdag	09:00 - 17:00
Vrijdag	09:00 - 17:00

Telefoon

+31383032630

Website

http://hemoclear.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer HemoClear nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.